# Brazilian and Italian Evaluation of Safety Using Tacrolimus-eluting Stent With Short-term Dual Antiplatelet Regimen

> **NCT01122719** · NA · TERMINATED · sponsor: **CID - Carbostent & Implantable Devices** · enrollment: 16 (actual)

## Conditions studied

- Stable Coronary Disease
- Unstable Coronary Disease
- Documented Silent Ischemia

## Interventions

- **DEVICE:** Drug Eluting Stent

## Key facts

- **NCT ID:** NCT01122719
- **Lead sponsor:** CID - Carbostent & Implantable Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-10
- **Primary completion:** 2011-11
- **Final completion:** 2013-03
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** slow inclusion, due to difficulties in obtaining the patients consent for the 2 months invasive follow-up, as required by protocol design.
- **Last updated:** 2018-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01122719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01122719, "Brazilian and Italian Evaluation of Safety Using Tacrolimus-eluting Stent With Short-term Dual Antiplatelet Regimen". Retrieved via MORVS 2026-10-18 from https://api.morvs.ai/clinical/NCT01122719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*